Bereaved caregivers of cancer patients Other
Conditions
Interventions
The study will consist of two phases. Phase 1 will involve two steps: an open trial with 10 bereaved caregivers who will receive the intervention and then provide feedback on their experience
and a manual refinement process that will involve 5 caregivers and 5 mental health clinicians. They will be provided with the manual and asked for feedback on the content, format, and language of the
Sponsors
European University Cyprus
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Having lost a loved one within the last 18 months and three months have passed since the loss 2. Cancer-related loss 3. Aged from 18 years 4. Being at risk for Prolonged Grief based on the PG-13-R scores (Prolonged Grief Disorder Revised; Prigerson et al.,2021) and on the TRIG scores (Texas Revised Inventory of Grief Greek version; Christodoulou et al. under preparation) 5. Able to communicate fluently in Greek.
Exclusion criteria
Exclusion criteria: 1. Having lost a non-adult son/daughter to cancer 2. Low grief risk based on PG-13-R scores and TRIG scores 3. Suffering from severe mental illness (i.e. psychosis, bipolar, severe depression, personality disorder) or substance abuse disorder, or dementia (self-report of previous diagnosis) 4. Substantial risk of suicidality (Based on SRS Suicide Risk Scale; Plutchik et al, 1989) 5. Receiving external psychological support in individual or group format
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Demographics are measured using an ad-hoc questionnaire at Screening, pre-intervention 2. Grief is measured using the Texas Revised Inventory of Grief (TRIG) at Screening, pre-intervention, post-intervention, one-month follow-up, and three-month follow-up 3. Prolonged grief is measured using the Prolonged Grief/PG-13 (Prigerson et al., 2009) at Screening, pre-intervention, post-intervention, one-month follow-up, and three-month follow-up 4. Suicide risk is measured using the Suicide Risk Scale (SRS) at Screening 5. Depression and anxiety are measured using the Depression-Anxiety-Stress Scale (DASS-21) at pre-intervention, post-intervention, one-month follow-up, and three-month follow-up 6. Resilience is measured using the CD-RISC (Connor & Davidson, 2003) at pre-intervention, post-intervention, one-month follow-up, and three-month follow-up 7. Post-traumatic growth is measured using the PTGI (Tedeschi & Calhoun, 1996) at pre-intervention, post-intervention, one-month follow-up, and three-month follow-up 8. Experiential avoidance is measured using the AAQ II (Bond et al., 2011) at pre-intervention, post-intervention, one-month follow-up, and three-month follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Cyprus
Contacts
Public ContactEleni Petkari
Outcome results
None listed